The patient, who presented to the clinical office complaining of dysuria, was diagnosed with a urinary tract infection and was prescribed TMP-SMX.
All articles by Cassandra Pardini
Study authors aimed to assess the clinical impact of a POC PCR test (the Cobas LIAT Influenza A/B assay) for the diagnosis of influenza.
Due to the limited amount of published literature analyzing treatment options for older chronic HCV infection patients, the study authors aimed to determine the efficacy and tolerability of glecaprevir/pibrentasvir in this population.
The patient, who had a history significant for cerebral palsy, seizures, and chronic constipation, presented complaining of 3 days of fever, nausea, vomiting, and anorexia.
The trial analyzed the antibody response of 103 asthmatic patients to the seasonal influenza vaccine.
In order to determine HCV reinfection rates following sustained virologic response (SVR) in the overall population as well as in PWID, the study authors analyzed data obtained from a population-based study that included >1.7 million people that were tested for HCV.
The study included 17,149,480 patients obtained from 2 national laboratory datasets who were screened between 2013 and 2016 based on an AB test.
ERCHIVES (Electronically Retrieved Cohort of HCV Infected Veterans) was utilized to identify all patients who received HCV treatment for at least 7 weeks as well as a propensity-score matched group who did not receive treatment.
In order to determine the association between CHC and parkinsonism, the study authors utilized the National Health Insurance Research Database in Taiwan to identify CHC patients between 2004 and 2012.
The review analyzed 168 patients treated with an oral DAA at a single center from 2015 to 2017.